Skip to content

Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses

Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05702541
Enrollment
16
Registered
2023-01-27
Start date
2023-01-24
Completion date
2023-02-21
Last updated
2024-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyopia

Keywords

Contact lenses

Brief summary

The purpose of this clinical trial is to assess the clinical performance of LID223194 Multifocal (MF) contact lenses and commercially available Air Optix plus HydraGlyde (AOHG) MF contact lenses. Eligible subjects will wear each study lens type in a cross-over fashion as randomized for approximately 2 days.

Detailed description

Subjects will be expected to attend 3 scheduled visits for an individual duration of participation of up to 10 days.

Interventions

Silicone hydrogel multifocal contact lenses

Silicone hydrogel multifocal contact lenses

Commercially available cleaning and disinfection system for silicone hydrogel contact lenses

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Able to understand and sign an consent form (ICF) that has been approved by an Institutional Review Board (IRB); * Willing to stop wearing habitual contact lenses for the duration of study participation; * Currently wearing multifocal soft contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months; * Other protocol-defined inclusion criteria may apply. Key

Exclusion criteria

* Any eye infection, inflammation, or abnormality or disease (including systemic) that contraindicates contact lens wear, as determined by the investigator; * Any use of systemic or ocular medications for which contact lens wear could be contraindicated, as determined by the investigator; * History of refractive surgery, or plan to have refractive surgery during the study; * Current or history of dry eye in either eye that would preclude contact lens wear, in the opinion of the investigator; * Monovision contact lens wear; * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Mean Binocular Visual Acuity (VA) With Study Lenses at 4 Meters (logMAR)Day 2 of each study lens type worn during the corresponding crossover periodVA was assessed binocularly (both eyes together) using a letter chart and measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with lower logMAR values indicating better visual acuity. No hypothesis testing was pre-specified for this endpoint.

Countries

United States

Participant flow

Recruitment details

Participants were recruited from one investigative site located in the United States.

Pre-assignment details

This reporting group includes all enrolled participants (16).

Participants by arm

ArmCount
LID223194 MF, Then AOHG MF
Lehfilcon A multifocal contact lenses worn first, followed by lotrafilcon B multifocal contact lenses, as randomized. Each product was worn in both eyes for 2 days in a daily wear modality. CLEAR CARE was used for daily cleaning and disinfection.
8
AOHG MF, Then LID223194 MF
Lotrafilcon B multifocal contact lenses worn first, followed by lehfilcon A multifocal contact lenses, as randomized. Each product was worn in both eyes for 2 days in a daily wear modality. CLEAR CARE was used for daily cleaning and disinfection.
8
Total16

Baseline characteristics

CharacteristicAOHG MF, Then LID223194 MFTotalLID223194 MF, Then AOHG MF
Age, Continuous60.4 years
STANDARD_DEVIATION 8
60.3 years
STANDARD_DEVIATION 5.9
60.3 years
STANDARD_DEVIATION 3.4
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
8 Participants15 Participants7 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Asian
1 Participants1 Participants0 Participants
Race/Ethnicity, Customized
Black or African American
0 Participants3 Participants3 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Other
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
White
7 Participants12 Participants5 Participants
Sex: Female, Male
Female
2 Participants4 Participants2 Participants
Sex: Female, Male
Male
6 Participants12 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
EG004
affected / at risk
deaths
Total, all-cause mortality
0 / 160 / 320 / 160 / 320 / 16
other
Total, other adverse events
0 / 160 / 320 / 160 / 320 / 16
serious
Total, serious adverse events
0 / 160 / 320 / 160 / 320 / 16

Outcome results

Primary

Mean Binocular Visual Acuity (VA) With Study Lenses at 4 Meters (logMAR)

VA was assessed binocularly (both eyes together) using a letter chart and measured in logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with lower logMAR values indicating better visual acuity. No hypothesis testing was pre-specified for this endpoint.

Time frame: Day 2 of each study lens type worn during the corresponding crossover period

Population: This analysis population includes all subjects/eyes exposed to any study lenses evaluated in this study.

ArmMeasureValue (MEAN)Dispersion
LID223194 MFMean Binocular Visual Acuity (VA) With Study Lenses at 4 Meters (logMAR)-0.06 logMARStandard Deviation 0.1
AOHG MFMean Binocular Visual Acuity (VA) With Study Lenses at 4 Meters (logMAR)-0.06 logMARStandard Deviation 0.07

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026